Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. administers 171.5 mln doses of COVID-19 vaccines - CDC

04/07/2021 | 04:28pm EDT

April 7 (Reuters) - The United States had administered 171,476,655 doses of COVID-19 vaccines in the country as of Wednesday morning and distributed 225,294,435 doses, the U.S. Centers for Disease Control and Prevention said.

The tally is for Moderna, Pfizer/BioNTech, and Johnson & Johnson's vaccines as of 6:00 a.m. ET on Wednesday, the agency said.

According to the tally posted on April 6, the agency had administered 168,592,075 doses of the vaccines, and distributed 219,194,215 doses.

The agency said 109,995,734 people had received at least one dose, while 64,422,618 people had been fully vaccinated as of Wednesday.

A total of 7,751,004 vaccine doses have been administered in long-term care facilities, the agency said. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Vinay Dwivedi)


© Reuters 2021
All news about MODERNA, INC.
02:05pMODERNA  : U.S. CDC Says Delivered 237,796,305 Doses Of Covid-19 Vaccine As Of A..
RE
12:29pTHE LATEST : CDC head warns against surging shots to Michigan
AQ
12:18pPFIZER  : Tweaked COVID vaccines in testing aim to fend off variants
AQ
08:36aMODERNA  : Canada set to receive 1M Pfizer-BioNTech doses, Moderna playing catch..
AQ
08:00aSpain expects first batch of single-dose Janssen shot within 48 hours
AQ
04:50aLABORATORIOS FARMACEUTICOS ROVI S A  : Spain's Rovi to Manufacture Active Ingred..
MT
04:30aSpanish drugmaker Rovi to make ingredients for Moderna COVID-19 vaccine
RE
03:41aMODERNA  : Rovi to make active agents for Moderna COVID-19 vaccine
RE
03:01aTAKE FIVE : Who's afraid of U.S. inflation?
RE
02:38aASTRAZENECA  : diabetes drug Farxiga fails in COVID-19 study
RE
More news
Financials (USD)
Sales 2021 17 037 M - -
Net income 2021 8 992 M - -
Net cash 2021 11 953 M - -
P/E ratio 2021 6,43x
Yield 2021 -
Capitalization 56 442 M 56 442 M -
EV / Sales 2021 2,61x
EV / Sales 2022 2,73x
Nbr of Employees 1 300
Free-Float 89,0%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 166,21 $
Last Close Price 140,92 $
Spread / Highest target 47,6%
Spread / Average Target 17,9%
Spread / Lowest Target -43,2%
EPS Revisions
Managers and Directors
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.34.89%56 442
LONZA GROUP AG-3.59%43 993
IQVIA HOLDINGS INC.15.90%39 822
CELLTRION, INC.-13.79%37 705
SEAGEN INC.-18.44%25 900
INCYTE CORPORATION-8.07%17 579